Vascular arginase and hypertension

Current Hypertension Reviews

Volumn 3, Issue 4, 2007, Pages 242-249

  Nelin, Leif D ^a   Stenger, Michael R ^a   Malleske, Daniel T ^a   Chicoine, Louis G ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Arginine; Nitric oxide synthase; Ornithine; Polyamines; Vascular remodeling

Indexed keywords

AMINO ACID TRANSPORTER; ARGINASE; ARGINASE 1; ARGINASE II; ARGINASE INHIBITOR; ARGININE; EFLORNITHINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; HYDRALAZINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; ORNITHINE DECARBOXYLASE; POLYAMINE; PROLINE; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UREA;

AMINO ACID METABOLISM; ANGIOGENESIS; BIOAVAILABILITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL; CELL PROLIFERATION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE MODEL; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HYDROLYSIS; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVIEW; SALT LOADING; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE; VASOCONSTRICTION; VASODILATATION;

EID: 37049011252     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340207782403881     Document Type: Review

References (79)

1. Chang IC, Zoghi B, Liao JC, Kuo L. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: Its implications in IL-13-inhibited nitric oxide production. J Inummol 2000; 165: 2134-41.
2. Koga T, Koshiyama Y, Gotoh T, et al. Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. Exp Eye Res 2002; 75: 659-67.
3. Louis CA, Reichner JS, Henry WL, et al. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol Regulatory Integrative Comp Physiol 1998; 274: R775-82.
4. Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YCT. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol Lung Cell Mol Physiol 1998; 275: L96-102.
5. Sonoki T, Nagasaki A, Gotoh T, et al. Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysacchride. J Biol Chem 1997; 272: 3689-3693.
6. Pauleau AL, Rutschman R, Lang R, Pernis A, Watowich SS, Murray PJ. Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol 2004; 172: 7565-73.
7. Gray MJ, Poljakovic; M, Kepka-Lenhart D, Morris SM. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ. Gene 2005; 353: 99-106.
8. Kimura T, Chowdhury S, Tanaka T, et al. CCAAT/enhancerbinding protein β is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagons in primary-cultured hepatocytes. FEBS Lett 2001; 494: 105-111.
9. Gotoh T, Chowdhury S, Takiguchi M, Mori M. The glucocorticoid-responsive gene cascade activation of the rat arginase gene through induction of C/ EBPβ. J Biol Chem 1997; 272: 3694-3698.
10. Chowdhury S, Gotoh T, Mori M, Takiguchi M. CCAAT/enhancer-binding protein β binds and activates while hepatocyte nuclear factor-4 does not bind but represses the liver-type arginase promoter. Eur J Biochem 1996; 236: 500-509.
11. Takiguchi M, Mori M. In vitro analysis of the rat liver-type arginase promoter. J Biol Chem 1991; 266: 9186-9193.
12. Albina JE, Mahoney EJ, Daley JM, Wesche DE, Morris SM, Reichner JS. Macrophage arginase regulation by CCAAT/enhancer-binding protein β. Shock 2005; 23: 168-172.
13. G-hydroxy-L-arginine during high-output NO production. Am J Physiol Heart Circ Physiol 1996; 271: H1988-98.
14. Morris SM, Kepka-Lenhart D, Chen LC. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol Endocrinol Metab 1998; 275: E740-47.
15. Salimuddin, Nagasaki A, Gotoh T, Isobe H, Mori M. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol Endocrinol Metab 1999; 277: E110-17.
16. Marathe C, Bradley MN, Hong C, et al. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 2006; 281: 32197-32206.
17. Grandvaux N, Gaboriau F, Harris J, tenOever BR, Lin R, Hiscott J. Regulation of arginase II by interferon regulatory factor 3 and the involvement of polyamines in the antiviral response. FEBS J 2005; 272: 3120-3131.
18. Nelin LD, Nash BE, Chicoine LG. Cytokine treatment increases arginine metabolism and uptake in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mot Physiol 2001; 281: L1232-39.
19. Chang IC, Liao JC, Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 2001; 61: 1100-6.
20. Li H, Meininger CJ, Hawker JR, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab 2001; 280: E75-82.
21. Schearer JD, Richards JR, Mills JD, Caldwell MD. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol Endocrinol Metab 1997; 272: E181-90.
22. Li H, Meininger CJ, Kelly KA, Hawker JR, Morris SM, Wu G. Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regulatory Integrative Comp Physiol 2002; 282: R64-9.
23. Janne J, Alhonen L, Lemonen P. Polyamines: from molecular biology to clinical applications. Ann Med 1991; 23: 241-259.
24. Nelin LD, Chicoine LG, Reber KM, English BK, Young TL, Liu Y. Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor. Am J Respir Cell Mol Biol 2005; 33: 394-401.
25. Schapira RK Wiessner JH, Morrisey JF, Almagro UA, Nelin LD. L-arginine uptake and metabolism by lung macrophages and neutrophils following intratracheal instillation of silica in vivo. Am J Respir Cell Mol Biol 1998; 19: 308-15.
26. Nelin LD, Wang X, Zhao Q, et al. MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge. Am J Physiol Cell Physiol, in press Epub ahead of print Apr 18.
27. Chicome LG, Paffett ML, Young TL, Nelin LD. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol. Lung Cell Mot Physiol 2004; 287: L60-8.
28. Thengchaisri N, Hein TW, Wang W, et al. Upregulation of arginase by H202 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 2006; 26: 2035-2042.
29. Kourembanas S, Maquillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium. under both nonnoxia and hypoxia. J Clin Invest 1993; 92: 99-104.
30. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89: 2035-40.
31. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995; 38: 87-104.
32. Zhang C, Hein TW, Wang W, Chang CI, Kuo L. Constitutive expression of argmase m nucrovascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 2001; 15: 1264-6.
33. Ryoo S, Lemmon CA, Soucy KG, et al. Oxidized low-denisty lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res 2006; 99: 951-60.
34. Hsu LL, Champion FIC, Campbell-Lee SA, et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007; 109: 3088-98.
35. Morris CR, Kato GJ, Poijakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. 2005; JAMA 294: 81-90,2005.
36. Chang IC, Liao JC, Koo L. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol Heart Circ Physiol 1998; 274: H342-8.
37. Wang WW, Jenkinson CP, Giscavage JM, et al. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysacchride. Biochem Biophys Res Commum 1995; 210: 1009-16.
38. Daghigh F, Fukuto JM, Ash DE. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-L-arginine: implications for the regulation of nitric oxide biosythesis by arginase. Biochem Biophys Res Com 1994; 202:174-180.
39. Waddington SN, Tam FWK, Cook HT, Cattell V. Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells. Am J Physiol Renal Physiol 1998; 274: F473-80.
40. Stanley KP, Chicome LG, Young TL, et al. Gene transfer with inducible nitric oxide synthase decreases production of urea by arginase in pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L298-306.
41. Que LG, George SE, Gotoh T, Mori M, Huang YCT. Effects of arginase isoforms on NO production by nNOS. Nitric Oxide 2002; 6:1-8.
42. Nelin LD, Krenz GS, Chicome LG, Dawson CA, Schapira RM. L-arginine uptake and metabolism following in vivo silica exposure in rat lungs. Am J Respir Cell Mol Biol 2002; 26: 348-55.
43. Garganta CL, Bond JS. Assays and kinetics of arginase. Anal Biochem 1986;154: 388-94.
44. Hardy TA, May JM. Coordinate regulation of L-arginme uptake and nitric oxide synthase activity in cultured endothelial cells. Free Radic Biol Med 2002; 32: 122-31.
45. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter I and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem 1997; 272: 31213-6.
46. Morrison RF, Seidel ER. Cell spreading and the regulation of ornithine decarboxylase. J Cell Sci 1995; 108: 3787-94.
47. Morrison RF, Seidel ER. Vascular endothelial cell proliferation: regulation of cellular polyamines. Cardiovasc Res 1995; 29: 841-7.
48. Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995; 35: 55-91.
49. Bachetti T, Comini L, Francolini G, et al. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 2004; 37: 515-23.
50. Wei LH, Wu G, Morris SM, Ignarro LJ. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci USA 2001; 98: 9260-4.
51. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A. 2001; 98: 4202-8.
52. Loyaga-Rendon RY, Sakamoto S, Beppu M, et al. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries. Atherosclerosis 2005; 178: 231-9.
53. Durante W, Liao L, Reyna SV, Peyton KJ, Schafer Al. Physiological cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle. FASEB J 2000; 14:1775-1783.
54. Durante W, Liao L, Reyna SV, Peyton KJ, Schafer AI. Transforming growth factor-β1 stimulates L-arginine transport and metabolism in vascular smooth muscle cells role in polyamine and collagen synthesis. Circulation 2001; 103: 1121-1127.
55. Geiser T, Jarreau PH, Atabai K, Matthay MA. Interleukin-1β augments in vitro alveolar epithelial repair. Am J Physiol Lung Cell Mot Physiol 2000; 279: L1184-90.
56. Madtes DK, Busby HK, Strandjord TP, Clark JG. Expression of transforming growth factor-alpha and epidermol growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 1994; 11: 540-51.
57. Chen K, Vita JA, Berk BC, Keaney JF Jr. c-Jun N-terminal kinase activation by hydrogen peroxide m endothelial cells involves src-dependent epidermal growth factor receptor transactivation. J Biol Chem 2001; 276: 16045-50.
58. 2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 2001; 88: 22-9.
59. Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothetial cells. J Immunol 2002; 169:2102-10.
60. Gotob T, Mori M. Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol 1999; 144: 427-34.
61. Klausen S, Hammermann R, Fuhmann M, et al. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 2001; 132: 1349-57.
62. Liu Y, Shepherd EG, Nelin LD. MAP kinase phosphatases-regulating the immune response. Nature Rev Immumol 2007; 7: 202-12.
63. Zhao Q, Wang X, Nelin LD, et al. MAP kinase phosphatase-1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 2006; 203: 131-40.
64. Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV, Liu Y. The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem 2004; 279, 54023-31.
65. Kolodziejski PJ, Koo JS, Eissa NT. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc Natl Acad Sci USA 2004; 101: 18141-6.
66. Rauh MJ, Kalesnikoff J, Hughes M, Sly L, Lam V. Role of Src homology 2-containing-inositol 5′-phosphatase (SHIP) in mast cells and macrophages. Biochem Soc Trans 2003; 31: 286-91.
67. Bonaparte KL, Hudson CA, Wu C, Massa PT. Inverse regulation of inducible nitric oxide synthase and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia. Glia 2006; 53: 827-35.
68. Ming XF, Barandier C, Viswambharan H, et al. Thrombin stimulates human endothetial arginase enzymatic activity via RhoA/ROCK pathway implications for atherosclerotic endothelial dysfunction. Circulation 2004; 110: 3709-3714.
69. Ynag L, Lewis CK Chandrasekbaran UK Kinney CK DiCorleto PE, Kashyap VS. Arginase activity is increased by thrombin: a mechanism for endothelial dysfunction in arterial thrombosis. J Am Coll Surg 2006; 203: 817-826.
70. Berkowitz DE, White R, Li D, et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003; 108: 2000-6.
71. White AR, Ryon S, Li D, et al. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 2006; 47: 245-51.
72. Demougeot C, Prigent-Tessier A, Marie C, Berthelot A. Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. J Hypertens 2005; 23: 971-78.
73. Demougeot C, Prigent-Tessier A, Bagnost T, et al. Time course of vascular arginase expression and activity in spontaneously hypertensive rats. Life Sci 2007; 80: 1128-34.
74. Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dah1 rats with salt-induced hypertension. Am J Physiol Regul Integr Comp, Physiol 2005; 288: R1057-62.
75. Rodriguez S, Richert L, Berthelot A. Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats. Clin Exp, Hypertens 2000; 22: 75-85.
76. Rodriguez S, Schleiffer R, Raul F, Richert L, Berthelot A. How could aortic arginase activity enhancement be involved in DOCA-salt hypertension? Clin Exp Hypertens 2004; 26: 1-12.
77. Zhang C, Hein TW, Wang W, et al. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 2004; 44: 935-43.
78. Holowatz LA, Kenney WL. Upregulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation m hypertensive human. J Physiol published online 2007, 10.1113/jphysiol 2007.128959.
79. Xu W, Kaneko FT, Zheng S, et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 2004; 18:1746-8.